Here are three things to know.
1. The decision slashes 15 percent of the company’s workforce in West Virginia. About 3,000 people will remain employed.
2. A majority of the affected employees work in jobs related to operations.
3. Mylan said the layoffs were because the plant “needed to be rightsized and less complex,” after having a discussion with the FDA. Mylan did not specify the details on the discussion with the federal agency.
More articles on supply chain:
Amazon drops plan to become a major pharmaceutical distributor: 7 things to know
GSK divests line of rare disease drugs
FDA OKs 1st AI medical device that screens patients without physician interpretation
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
